There is a bidirectional interaction between nutrition, infection, and immunity: immune response is compromised if nutrition is insufficient, predisposing people to infections, while at the same time poor nutritional status can be aggravated by the same immune response to infection
Taking tirzepatide on the same day each week, preferably when patients can rest if nausea occurs, improves tolerability
Each has a similar overall safety profile but may differ in specific side effect frequencies
BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
While peptide science itself is fascinating, clinical interest is not the same as clinical proof